Skip to main content

Dextroamphetamine/Amphetamine

FDA recalls

4 rows

DateCompany and reasonClass
Jun 25, 2026Lannett Company Inc.
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.		Class II · Ongoing
Aug 27, 2025Granules Pharmaceuticals Inc.
Failed Impurities/Degradation Specifications:		Class III · Ongoing
Oct 8, 2020Ani Pharmaceuticals, Inc.
Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.		Class III · Terminated
Feb 12, 2013Actavis Elizabeth LLC
Failed Dissolution Specification: This product recall is due to the product lot # 50077231 exceeding dissolution specifications. All other test specifications were met.		Class III · Terminated

← Back to Dextroamphetamine/Amphetamine

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).